VSee Health Appeals NASDAQ Staff Delisting Notice
VSee Health (NASDAQ:VSEE) announced it is appealing a NASDAQ Staff Determination to delist its common stock from the Nasdaq Capital Market. The delisting notice was received on August 5th, 2025, citing non-compliance with filing requirements for the 2024 Annual Report and Q1 2025 Quarterly Report.
The company has requested a hearing before the Nasdaq Listing Qualifications Panel, which automatically stays the delisting for 15 days. VSee Health plans to request an extended stay pending the hearing. If the appeal is unsuccessful, the company's stock could move to trading on the OTC Bulletin Board.
VSee Health (NASDAQ:VSEE) ha annunciato che presenterà ricorso contro una determinazione del personale del NASDAQ che ne dispone la cancellazione delle azioni ordinarie dal Nasdaq Capital Market. L'avviso di delisting è stato ricevuto il 5 agosto 2025, indicando la mancata conformità agli obblighi di deposito per il Rapporto annuale 2024 e il Rapporto trimestrale del primo trimestre 2025.
L'azienda ha chiesto un'udienza davanti al Nasdaq Listing Qualifications Panel, che sospende automaticamente il delisting per 15 giorni. VSee Health intende richiedere una proroga della sospensione in attesa dell'udienza. Se l'appello dovesse fallire, le azioni della società potrebbero essere trasferite al OTC Bulletin Board.
VSee Health (NASDAQ:VSEE) anunció que apelará una determinación del personal de NASDAQ para excluir sus acciones ordinarias del Nasdaq Capital Market. La notificación de delisting se recibió el 5 de agosto de 2025, citando el incumplimiento de los requisitos de presentación del Informe anual 2024 y del Informe trimestral del primer trimestre de 2025.
La empresa ha solicitado una audiencia ante el Nasdaq Listing Qualifications Panel, lo que suspende automáticamente el delisting durante 15 días. VSee Health planea solicitar una prórroga de la suspensión mientras se celebra la audiencia. Si la apelación no prospera, las acciones de la compañía podrían pasar a cotizar en el OTC Bulletin Board.
VSee Health (NASDAQ:VSEE)는 Nasdaq Capital Market에서 보통주를 상장폐지하려는 NASDAQ 직원의 결정에 대해 항소한다고 발표했습니다. 상장폐지 통지는 2025년 8월 5일에 접수되었으며, 2024 연례보고서와 2025년 1분기 분기보고서 제출 의무 불이행을 이유로 들었습니다.
회사는 Nasdaq Listing Qualifications Panel에 심리를 요청했으며, 이로 인해 상장폐지는 자동으로 15일간 유예됩니다. VSee Health는 심리가 열릴 때까지 유예 기간 연장을 신청할 계획입니다. 항소가 실패할 경우 회사 주식은 OTC Bulletin Board에서 거래될 수 있습니다.
VSee Health (NASDAQ:VSEE) a annoncé qu'elle faisait appel d'une décision du personnel du NASDAQ visant à radier ses actions ordinaires du Nasdaq Capital Market. L'avis de radiation a été reçu le 5 août 2025, invoquant le non-respect des obligations de dépôt pour le rapport annuel 2024 et le rapport trimestriel du 1er trimestre 2025.
La société a demandé une audience devant le Nasdaq Listing Qualifications Panel, ce qui suspend automatiquement la radiation pendant 15 jours. VSee Health prévoit de demander une prolongation de cette suspension en attendant l'audience. Si l'appel échoue, les actions de la société pourraient passer à une cotation sur le OTC Bulletin Board.
VSee Health (NASDAQ:VSEE) teilte mit, dass das Unternehmen gegen eine Entscheidung der NASDAQ-Mitarbeiter zur Streichung seiner Stammaktien vom Nasdaq Capital Market Berufung einlegt. Die Delisting-Mitteilung ging am 5. August 2025 ein und nannte die Nicht-Einhaltung der Einreichungsanforderungen für den Jahresbericht 2024 und den Quartalsbericht für das 1. Quartal 2025 als Grund.
Das Unternehmen hat eine Anhörung vor dem Nasdaq Listing Qualifications Panel beantragt, wodurch das Delisting automatisch für 15 Tage ausgesetzt wird. VSee Health beabsichtigt, eine Verlängerung der Aussetzung bis zur Anhörung zu beantragen. Sollte die Berufung erfolglos bleiben, könnten die Aktien des Unternehmens zum OTC Bulletin Board wechseln.
- None.
- Company failed to file 2024 Annual Report and Q1 2025 Quarterly Report
- Risk of delisting from NASDAQ Capital Market
- Potential downgrade to OTC Bulletin Board trading
SAN JOSE, CA / ACCESS Newswire / August 12, 2025 / VSee Health, Inc. (Nasdaq:VSEE) (the "Company"), a leader in telehealth solutions, today announced that it has requested a hearing before a Nasdaq Listing Qualifications Panel to appeal an earlier Staff Determination to delist the Company's common stock from the Nasdaq Capital Market.
VSee Health received a letter from the Nasdaq Stock Market ("Nasdaq") on August 5th, 2025 indicating that the Company did not comply with the NASDAQ's filing requirements because it had not filed its Annual Report on Form 10-K for period ending December 31, 2024, and its Quarterly Report on Form 10-Q for the period ending March 31, 2025. Following procedures set forth in the Nasdaq rules, VSee Health has requested a hearing before a Nasdaq Listing Qualifications Panel (the "Panel") to review the Staff Determination. The appeal will automatically stay the delisting for 15 days. The Company plans to request a further stay pending the hearing, which, if approved, would allow the Company to continue to trade on the Nasdaq Capital Market. There can be no assurance however, that the Panel will grant the Company request for continued listing on the Nasdaq Capital Market or such extended stay.
In the event that the Panel denies the Company's request for continued listing on the Nasdaq Capital Market, the Company's common stock could be eligible to trade on the OTC Bulletin Board.
About VSee Health
VSee Health, Inc. (Nasdaq:VSEE) is a leading provider of telehealth solutions, specializing in real-time virtual care, clinical review, and billing services. Its technology powers healthcare networks and organizations worldwide, enabling seamless patient-provider interactions and ensuring efficient care delivery. Field-hardened on over 1.5M HIPAA-compliant video encounters every month, VSee Health's highly scalable, customizable telehealth building blocks each meet stringent security standards. VSee Health has deployed services in over 50 countries, including Iraq, Syria, Marshall Islands and El Salvador. Its clients include NASA, US Department of Health and Human Services, McKesson, Magellan, DaVita, GE, countless startups, and the entire country of Qatar. VSee Health also provides tailored solutions for critical shortage areas such as critical care and teleradiology. VSee Health is committed to empowering high quality healthcare access and reducing physician burnout and workforce shortages through its telehealth technology. For more information, please visit www.vseehealth.com.
Forward-Looking Statements
Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.
Contact:
VSee Health
Anne Chang
media@vsee.com
VSee Investor Contact:
Milton Chen
VSee Health
investor@vsee.com
SOURCE: VSee Health, Inc.
View the original press release on ACCESS Newswire
FAQ
Why is VSee Health (VSEE) facing NASDAQ delisting in 2025?
What happens to VSEE stock if the NASDAQ delisting appeal fails?
When did VSee Health receive the NASDAQ delisting notice?
How long will VSee Health's delisting be stayed during the appeal process?
What is VSee Health doing to prevent NASDAQ delisting?
